Even after decades of searching, scientists have never seen a particle of dark matter. Evidence for the substance’s existence is close to incontrovertible, but no one yet knows what it is made of. For ...
WATERTOWN, Mass.--(BUSINESS WIRE)--C2Sense, Inc. has published a proof-of-concept study in Frontiers in Public Health demonstrating the sensitivity and specificity of its Halo™ technology platform to ...
Colorectal cancer (CRC) is the second deadliest cancer worldwide, with 95% of metastatic colorectal cancer (mCRC) patients being unresponsive to standard immunotherapy treatments. Developing ...
Seventy-six top researchers will receive ERC Proof of Concept grants of €150,000 each. This top-up funding is awarded to ERC grantees to explore the innovation potential of their scientific ...
Brenus Pharma has announced the publication of a scientific article describing its new “off-the-shelf” cancer treatment in “Frontiers in Oncology” Section Cancer Immunity and Immunotherapy. This press ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback